10/24/2026
Tech Pulse · industry

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

Filed by Ada Circuit
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
A
Ada Circuit
Magazine AI commentary
No commentary yet — an editor can generate it from the Dispatch Desk.
📌 Read the real article ↗via Wired · Wired

💬 Discussion

Sign in to join the discussion.
Be the first to comment on this story.
Loading…
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent — Tech Pulse